Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: A pilot study

Journal of Periodontology

Volumn 81, Issue 7, 2010, Pages 1056-1063

  Duarte, Poliana Mendes ^a,b   Da Rocha, Marcelo ^a   Sampaio, Eduardo ^a   Mestnik, Maria Josefa ^a   Feres, Magda ^a   Figueiredo, Luciene Cristina ^a   Bastos, Marta Ferreira ^a   Faveri, Marcelo ^a  

^a GUARULHOS UNIVERSITY   (Brazil)

^b 229 Centro   (Brazil)

Author keywords

Cytokines; Enzyme linked immunosorbent assay; Periodontitis; Root planing; Serum

Indexed keywords

AUTACOID; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGGRESSIVE PERIODONTITIS; ARTICLE; BLOOD; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GINGIVA BLEEDING; HUMAN; MALE; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PILOT STUDY; PREVENTIVE DENTISTRY; TOOTH PLAQUE;

ADULT; AGGRESSIVE PERIODONTITIS; CHRONIC PERIODONTITIS; CYTOKINES; DENTAL PLAQUE; DENTAL PROPHYLAXIS; DENTAL SCALING; FEMALE; FOLLOW-UP STUDIES; GINGIVAL HEMORRHAGE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-4; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PILOT PROJECTS; ROOT PLANING; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77954467695     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.090732     Document Type: Article

References (45)

1. Williams RC, Offenbacher S. Periodontal medicine: The emergence of a new branch of periodontology. Periodontol 2000 2000;23:9-12.
2. Chun YH, Chun KR, Olguin D, Wang H.L. Biological foundation for periodontitis as a potential risk factor for atherosclerosis. J Periodontal Res 2005;40:87-95.
3. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71: 1528-1534.
4. Meurman JH, Sanz M, Janket S.J. Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 2004;15:403-413.
5. Eklund C.M. Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 2009;48:111-136.
6. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
7. Wajant H, Pfeffer K, Pfizenmaier K, Scheurich P. Tumor necrosis factors in 1998. Cytokine Growth Factor Rev 1998;9:297-302.
8. Boyce BF, Li P, Yao Z, et al. TNF-alpha and pathologic bone resorption. Keio J Med 2005;54:127-131.
9. Tesmer LA, Lundy SK, Sarkar S, Fox D.A. Th17 cells in human disease. Immunol Rev 2008;223:87-113.
10. Patel DN, King CA, Bailey SR, et al. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem 2007;282:27229-27238.
11. Tan ZY, Bealgey KW, Fang Y, Gong YM, Bao S. Interleukin-23: Immunological roles and clinical implications. Int J Biochem Cell Biol 2009;41:733-735.
12. Mosmann TR, Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46:111-147.
13. te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor C.G. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 1990;76:1392-1397.
14. Ryan S, Taylor CT, McNicholas W.T. Systemic inflammation: A key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009;64:631-636.
15. Liang J, Zheng Z, Wang M, et al. Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes. J Int Med Res 2009;37:862-866.
16. Jafarzadeh A, Esmaeeli-Nadimi A, Nough H, Nemati M, Rezayati M.T. Serum levels of interleukin (IL)-13, IL- 17 and IL-18 in patients with ischemic heart disease. Anadolu Kardiyol Derg 2009;9:75-83.
17. Sumarac-Dumanovic M, Stevanovic D, Ljubic A, et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 2009;33:151-156.
18. Bradley J.R. TNF-mediated inflammatory disease. J Pathol 2008;214:149-160.
19. Ebersole JL, Machen RL, Steffen MJ, Willmann D.E. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997;107:347-352.
20. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow J.S. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000;79: 49-57.
21. Buhlin K, Hultin M, Norderyd O, et al. Risk factors for atherosclerosis in cases with severe periodontitis. J Clin Periodontol 2009;36:541-549.
22. Loos B.G. Systemic markers of inflammation in periodontitis. J Periodontol 2005;76:2106-2115.
23. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson R.F. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol 2003; 30:334-340.
24. Paraskevas S, Huizinga JD, Loos B.G. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35: 277-290.
25. Araujo MW, Hovey KM, Benedek JR, et al. Reproducibility of probing depth measurement using a constant- force electronic probe: Analysis of inter- and intraexaminer variability. J Periodontol 2003;74:1736-1740.
26. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25: 229-235.
27. Armitage G.C. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
28. Faveri M, Figueiredo LC, Duarte PM, Mestnik MJ, Mayer MP, Feres M. Microbiological profile of untreated subjects with localized aggressive periodontitis. J Clin Periodontol 2009;36:739-749.
29. Ikezawa I, Tai H, Shimada Y, Komatsu Y, Galicia JC, Yoshie H. Imbalance between soluble tumour necrosis factor receptors type 1 and 2 in chronic periodontitis. J Clin Periodontol 2005;32:1047-1054.
30. Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madaliński K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003;30: 1046-1052.
31. Nakajima T, Honda T, Domon H, et al. Periodontitisassociated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res 2010;45:116-122.
32. Havemose-Poulsen A, Sørensen LK, Stoltze K, Bendtzen K, Holmstrup P. Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 2005;76:2276-2285.
33. Sørensen LK, Havemose-Poulsen A, Bendtzen K, Holmstrup P. Aggressive periodontitis and chronic arthritis: Blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors. J Periodontol 2009;80:282-289.
34. Ramirez-Tortosa MC, Quiles JL, Battino M, et al. Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers. Nutr Metab Cardiovasc Dis 2010:20:133-139.
35. Yun F, Firkova EI, Xun H, Jun-Qi L. Effects of surgical periodontal therapy on serum levels of TNF-alpha in patients with chronic periodontitis. Folia Med (Plovdiv) 2007;49:37-40.
36. Ikezawa-Suzuki I, Shimada Y, Tai H, Komatsu Y, Tanaka A, Yoshie H. Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitis. J Clin Periodontol 2008;35: 961-968.
37. Yamazaki K, Honda T, Oda T, et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 2005;40:53-58.
38. Behle JH, Sedaghatfar MH, Demmer RT, et al. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 2009;36: 287-294.
39. Honda T, Aoki Y, Takahashi N, et al. Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease. Clin Chim Acta 2008; 395:137-141.
40. Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005;32:383-389.
41. Borch TS, Løbner M, Bendtzen K, Holmstrup P, Nielsen C.H. Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis. J Periodontol 2009;80:800-807.
42. Lester SR, Bain JL, Johnson RB, Serio F.G. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol 2007;78:1545-1550.
43. McFarlane CG, Meikle M.C. Interleukin-2, interleukin-2 receptor and interleukin-4 levels are elevated in the sera of patients with periodontal disease. J Periodontal Res 1991;26:402-408.
44. Kobayashi H, Nagasawa T, Aramaki M, Mahanonda R, Ishikawa I. Individual diversities in interferon gamma production by human peripheral blood mononuclear cells stimulated with periodontopathic bacteria. J Periodontal Res 2000;35:319-328.
45. Takahashi K, Ohyama H, Kitanaka M, et al. Heterogeneity of host immunological risk factors in patients with aggressive periodontitis. J Periodontol 2001;72: 425-437.